BBus (QUEENSLAND UNIVERSITY OF TECHNOLOGY)
Ross Dobinson has extensive corporate advisory and investment banking experience. He has also taken an entrepreneurial role in the commercialisation of technologies in a range of fields, including: agricultural science, pharmaceuticals, environmentally-friendly packaging, medical devices, drug delivery technology and nutriceuticals. Mr Dobinson has experience in company formation, seed, mezzanine and IPO funding, specialising in the life sciences sector, where he has been a founding director, investor and executive of listed and unlisted companies.
Commencing as a chartered accountant with Hungerfords, Mr Dobinson has held positions as a Director of the listed stockbroking firm of Jacksons Limited, Head of Corporate Advisory Services at the stockbroking firm operated by National Australia Bank Limited (A.C. Goode & Co. Ltd), Director of National Australia Corporate Advisory Limited, and Director of Corporate Advisory of Dresdner Australia Proprietary Limited.
Mr Dobinson has taken two highly successful biotechnology companies from pre-seed stage to listed status with a current market capitalisation of $1.2 billion. In addition, he has been involved in venture capital initiatives in Australia, Europe and the United States.
Mr Dobinson is currently Chairman of Acrux Limited, Micronix Pty Ltd, Diagnotech Pty Ltd, Farm By Nature Pty Ltd and TPI Enterprises Ltd. He is also a Director of Starpharma Holdings Limited, Origin Capital Limited, PharmaQest Pty Ltd, Healthfarm Fine Foods Pty Ltd and Racing Victoria Limited.
Mr Dobinson was appointed Executive Chairman of the Company on 21 July 2010.
Steven M Skala AO
BA, LL.B (HONS) (UNIVERSITY OF QLD),
BCL (OXFORD UNIVERSITY)
Steven Skala is Vice Chairman, Australia and New Zealand of Deutsche Bank AG. He is a former commercial lawyer with more than 20 years experience in commercial law. Between 1982 and 1985, he was a partner of law firm Morris Fletcher and Cross (now Minter Ellison). Between 1985 and 2004 he was a partner of law firm, Arnold Bloch Leibler, and was Head of its Corporate and Commercial Practice for several years.
Mr Skala is a Director of the Australian Broadcasting Corporation, Deutsche Australia Limited, Wilson HTM Investment Group Limited, and The Centre for Independent Studies and he is Deputy Chairman of the General Sir John Monash Foundation. He is also Vice President of The Walter and Eliza Hall Institute for Medical Research and was previously Chairman of Film Australia Limited and The Australian Centre for Contemporary Arts and a director of Max Capital Group Limited and The Australian Ballet.
Mr Skala has been a Director of the Company since 17 May 2002. He was Chairman of the Company from 2002 until 30 June 2008. He was reappointed as Chairman on 2 October 2009 and resigned as Chairman on 21 July 2010. He is also a member of the Audit and Risk Management and Remuneration Committees
Hugh M Morgan AC
LLB, BCOMM (THE UNIVERSITY OF MELBOURNE)
Hugh Morgan is Principal of First Charnock Pty Ltd, and a member of the Lafarge International Advisory Board. He is also a Trustee of The Asia Society New York, President of the National Gallery of Victoria Foundation and Chairman of the Order of Australia Association Foundation.
Mr Morgan was a Director of the Board of the Reserve Bank of Australia until July 2007 and he was President of the Business Council of Australia from 2003 to 2005. He is also immediate Past President of the Australia Japan Business Co-operation Committee and immediate Past Co-Chair of the Commonwealth Business Council, and continuing Director.
Mr Morgan was Chief Executive Officer of WMC Limited from 1986 to 2003. He was a Director of Alcoa of Australia from 1977 to 1998 and a Director of Alcoa Inc from 1998 to 2001.
Mr Morgan has been a Director of the Company since 10 May 2007. He is Chairman of the Audit and Risk Management Committee and a member of the Remuneration Committee.
Professor Jonathan West
BA (UNIVERSITY OF SYDNEY), PHD (HARVARD UNIVERSITY)
Professor Jonathan West is the Director of the Australian Innovation Research Centre. Prior to assuming his current appointment, he taught for 18 years at the Harvard University Graduate School of Business Administration, where he was Associate Professor, founding Director of the Harvard University Life Sciences Initiative, and from 1998-1999 the Novartis Faculty Research Fellow. He has been Visiting Professor at Hitotsubashi University and the Nomura School of Advanced Management in Tokyo, Japan and Visiting Professor at the University de Paris IX-Dauphine, Sorbonne.
Professor West is also Chairman of the Asia Advisory Council of Bunge Ltd, one of the world’s largest agribusiness processing and trading companies, and has served as an advisor to other major corporations and several Governments around the world, including in the life sciences field, DuPont, Roche, Novartis, Syngenta and the J.R. Simplot Company, along with the Governments of Singapore, Japan, Hong Kong and France. He was a member of the Scientific Advisory Board of the Novartis Agricultural Discovery Institute in La Jolla, California. In Australia, he has served on the Prime Minister’s Science, Engineering, Innovation Council’s Working Group on Science and Technology in China and India and in 2006 was ‘Eminent Thinker in Residence’ with the Premier of NSW.
Professor West has been a Director of the Company since 7 November 2005. He is Chairman of the Remuneration Committee and a member of the Audit and Risk Management Committee.
Professor Marilyn A Anderson
BSc (Hons) (The University of Melbourne), PhD (La Trobe University)
Executive Director, Chief Science Officer
Professor Marilyn Anderson is a founding scientist of Hexima. She has over 30 years experience in scientific research in the area of plant biochemistry and genetics. After completing a BSc Honours at The University of Melbourne and a PhD in Biochemistry at La Trobe University, Professor Anderson spent seven years in the United States working on diabetes at the University of Miami and oncogenes at Cold Spring Harbor Laboratory.
She is a Professor of Biochemistry at La Trobe University and an Associate Professorial Fellow in the Botany School at The University of Melbourne. She was appointed Hexima’s Chief Science Officer in July 2009. Professor Anderson was a director at South East Water Limited for over 10 years prior to her appointment to the board of City West Water in 2008. She is a Fellow of the Australian Academy of Science, of the Australian Academy of Technological Sciences and Engineering and of the Australian Institute of Company Directors.
She was appointed a Director of the company on 23 November 2010.